Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-12-16Clinical Trial Update: Genetic Variants Replication Study Associated With Dependence on Sulfonylurea in Participants With Type 2 Diabetes [Phase 4]
Phase 4 replication genetic variants study exploring dependence on sulfonylurea in participants with type 2 diabetes has completed.
-
CLINICAL_TRIALS trial_result · 2020-12-14Clinical Trial Update: Rosuvastatin/Ezetimibe Versus Rosuvastatin in ASCVD Patients With Type 2 DM [Phase 4]
A Phase 4 trial comparing rosuvastatin/ezetimibe combination vs rosuvastatin alone in patients with ASCVD and type 2 diabetes mellitus has c…
-
CLINICAL_TRIALS trial_result · 2020-12-14Clinical Trial Update: High-intensity Rosuvastatin vs. Moderate-intensity Rosuvastatin/Ezetimibe in High Atherosclerotic Cardiovascular Disease Risk Patients With Type 2 Diabetes [Phase 4]
Phase 4 clinical trial comparing high-intensity rosuvastatin versus moderate-intensity rosuvastatin/ezetimibe in patients with high ASCVD ri…
-
CLINICAL_TRIALS trial_result · 2020-12-14Clinical Trial Update: Dual Add-on Therapy in Type 2 Diabetes Poorly Controlled With Metformin Monotherapy [Phase 3]
Phase 3 trial update for dual add-on therapy in type 2 diabetes inadequately controlled on metformin monotherapy.
-
CLINICAL_TRIALS trial_result · 2020-12-14Clinical Trial Update: Vascular Endothelium Changes After Bariatric Surgery (Endothelial Progenitor Cells) [NA]
Clinical trial update examining changes in vascular endothelium after bariatric surgery and the role of endothelial progenitor cells. The st…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-12-11Clinical Trial Update: Safety And Efficacy Of Empagliflozin In Pakistani Muslim Population With Type Ii Diabetes Mellitus [Phase 4]
A Phase 4 clinical trial evaluating safety and efficacy of empagliflozin in Pakistani Muslim population with Type II diabetes mellitus has b…
-
CLINICAL_TRIALS trial_result · 2020-12-11Clinical Trial Update: A Clinical Trial to Evaluate the Preference Regarding Convenience of Medication and Efficacy/Safety of SUGAMET®XR Tablet 5/1000mg [Phase 4]
A Phase 4 clinical trial evaluating patient preference for convenience of SUGAMET XR Tablet 5/1000 mg and its efficacy/safety in type 2 diab…
-
CLINICAL_TRIALS research · 2020-12-09Clinical Trial Update: Diabetes Prevention Program Lifestyle Intervention in the Marshallese Population [NA]
Clinical trial update on a lifestyle intervention for preventing diabetes in the Marshallese population; study completed with posted results…
-
CLINICAL_TRIALS trial_result · 2020-12-07Clinical Trial Update: Trial of an Intervention to Improve Metformin Persistence and Adherence [Phase 4]
Phase 4 trial update evaluating an intervention to improve metformin persistence and adherence; study completed with results posted in 2020.
-
FDA approval · 2020-12-04FDA Approved: JANUMET XR — Supplemental Application (Merck Sharp & Dohme LLC)
FDA approved a supplemental application for JANUMET XR (sitagliptin and metformin hydrochloride) from Merck Sharp & Dohme LLC.
-
FDA approval · 2020-12-04FDA Approved: JANUVIA — Supplemental Application (Merck Sharp & Dohme LLC)
The FDA approved a supplemental application for Januvia (sitagliptin) from Merck Sharp & Dohme LLC, to the existing NDA for the product.
-
FDA approval · 2020-12-04FDA Approved: JANUMET — Supplemental Application (Merck Sharp & Dohme LLC)
The FDA approved a supplemental application for JANUMET (sitagliptin and metformin hydrochloride) submitted by Merck Sharp & Dohme LLC.
-
CLINICAL_TRIALS trial_result · 2020-12-02Clinical Trial Update: Study to Evaluate Safety and Efficacy of Dapagliflozin in Patients With Type 2 Diabetes Mellitus Aged 10-24 Years [Phase 3]
Phase 3 trial evaluating safety and efficacy of dapagliflozin in youths aged 10-24 with type 2 diabetes has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-12-01Clinical Trial Update: Safety and Efficacy of Exenatide as Monotherapy and Adjunctive Therapy to Oral Antidiabetic Agents in Adolescents With Type 2 Diabetes [Phase 3]
Phase 3 trial evaluating exenatide as monotherapy and adjunctive therapy for adolescents with type 2 diabetes completed with posted results.
-
CLINICAL_TRIALS trial_result · 2020-11-24Clinical Trial Update: Remission Evaluation of a Metabolic Intervention in Type 2 Diabetes With Forxiga [Phase 4]
Phase 4 trial evaluating remission-related outcomes of a metabolic intervention with Forxiga in adults with Type 2 Diabetes Mellitus.
-
CLINICAL_TRIALS trial_result · 2020-11-23Clinical Trial Update: Specified Drug-Use Survey of Alogliptin and Metformin Hydrochloride Combination Tablets "Survey on Long-term Use in Type 2 Diabetes Mellitus Patients With Renal or Hepatic Impairment or Advanced Age"
Completed clinical trial evaluating long-term use of alogliptin and metformin hydrochloride combination tablets in type 2 diabetes patients …
-
CLINICAL_TRIALS trial_result · 2020-11-18Clinical Trial Update: A Dose-Finding Study of RO4998452 in Patients With Diabetes Mellitus [Phase 2]
A Phase 2 dose-finding trial of RO4998452 in patients with Type 2 diabetes has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-11-17Clinical Trial Update: Tofogliflozin GLP-1 Analogue Combination Trial [Phase 4]
Phase 4 trial updating results for tofogliflozin combined with a GLP-1 analogue in type 2 diabetes mellitus.
-
CLINICAL_TRIALS trial_result · 2020-11-16Clinical Trial Update: Cognitive Behavioral Therapy for Adherence in Patients With Type 2 Diabetes [NA]
A completed clinical trial evaluating cognitive behavioral therapy to improve adherence in patients with type 2 diabetes and depression.
-
CLINICAL_TRIALS trial_result · 2020-11-13Clinical Trial Update: Remission Evaluation of a Metabolic Intervention for Type 2 Diabetes With IGlarLixi [Phase 3]
Phase 3 trial update evaluating remission of Type 2 Diabetes mellitus with metabolic intervention using IGlarLixi.
-
CLINICAL_TRIALS trial_result · 2020-11-10Clinical Trial Update: Stepping-down Approach in Patients With Chronic Poorly-controlled Diabetes on Advanced Insulin Therapy? [NA]
A completed clinical trial investigating step-down approaches for patients with chronic poorly controlled type 2 diabetes on advanced insuli…
-
CLINICAL_TRIALS research · 2020-11-09Clinical Trial Update: Reducing Plasma Glucose Effect of Cinnamon in Type 2 Diabetic Patients in the Municipality of Comasagua [Phase 2, Phase 3]
A completed clinical trial investigating cinnamon's effect on reducing plasma glucose in adults with Type 2 diabetes (Phase 2/Phase 3).
-
CLINICAL_TRIALS trial_result · 2020-11-06Clinical Trial Update: Longitudinal Phenotyping of Bariatric Surgery Patients
A completed clinical trial studying longitudinal phenotyping in bariatric surgery patients with obesity and type 2 diabetes; results posted …
-
CLINICAL_TRIALS trial_result · 2020-11-02Clinical Trial Update: Study Evaluating Safety, Tolerability, And Action Of OAP-189 In Subjects With Type 2 Diabetes On Metformin [Phase 1]
Phase I trial updating safety, tolerability, and action of OAP-189 in adults with type 2 diabetes on metformin; study completed with results…
-
FDA approval · 2020-10-30FDA Approved: TRIJARDY XR — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)
The FDA approved a supplemental application for TRIJARDY XR, a fixed-dose combination tablet of empagliflozin, linagliptin, and metformin hy…